SER-109
Seres Therapeutics
['$mcrb']
. and present results from ecospor iv phase 3 study of vowst , a microbiota-based oral therapeutic for prevention of recurrence of c. difficile infection, at the digestive disease week (ddw) annual meeting $mcrb #ddw2023
MTIG is dedicated to enhancing the regulatory, investment, and commercial environment to accelerate microbiome therapeutic drug product development.